(Q34751971)

English

Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

0 references

0 references

0 references

chronic heart failure

1 reference

based on heuristic

inferred from title

5

object named as

Faiez Zannad

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1

object named as

Bertram Pitt

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Stefan D. Anker

2

object named as

Stefan D Anker

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Dalane W Kitzman

4

object named as

Dalane W Kitzman

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

David A Bushinsky

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

I-Zu Huang

6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PEARL-HF Investigators

7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

5 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

820-828

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Aldosterone: role in edematous disorders, hypertension, chronic renal failure, and metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069389

7 July 2018

Understanding the risk of hyperkalaemia in heart failure: role of aldosterone antagonism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069389

7 July 2018

Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069389

7 July 2018

Colonic potassium handling.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069389

7 July 2018

Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069389

7 July 2018

Dual blockade of the renin-angiotensin-aldosterone system in cardiac and renal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069389

7 July 2018

Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069389

7 July 2018

The frequency of hyperkalemia and its significance in chronic kidney disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069389

7 July 2018

Hypertension management in patients with chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069389

7 July 2018

A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069389

7 July 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069389

7 July 2018

Hypokalemia and hyperkalemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069389

7 July 2018

The electrolyte content faeces

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069389

7 July 2018

Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ502

21 January 2018

Mechanisms of impaired potassium handling with dual renin-angiotensin-aldosterone blockade in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ502

21 January 2018

Spironolactone use and renal toxicity: population based longitudinal analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ502

21 January 2018

Safety of spironolactone use in ambulatory heart failure patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ502

21 January 2018

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ502

21 January 2018

Potassium homeostasis and clinical implications

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHQ502

21 January 2018

Hyperkalemia risk in chronic kidney disease: deterrent to the use of aldosterone receptor antagonism or not.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069389

26 October 2018

Ionic constituents and osmolality of gastric and small-intestinal fluids after eating

1 reference

https://pubmed.ncbi.nlm.nih.gov/21208974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21208974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21208974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/EURHEARTJ/EHQ502

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34751971&oldid=1957527207"